Krsnaa Diagnostics Limited (NSE:KRSNAA)
709.15
-22.10 (-3.02%)
At close: Dec 29, 2025
Krsnaa Diagnostics Revenue
Krsnaa Diagnostics had revenue of 2.06B INR in the quarter ending September 30, 2025, with 10.55% growth. This brings the company's revenue in the last twelve months to 7.60B, up 11.51% year-over-year. In the fiscal year ending March 31, 2025, Krsnaa Diagnostics had annual revenue of 7.17B with 15.74% growth.
Revenue (ttm)
7.60B
Revenue Growth
+11.51%
P/S Ratio
3.03
Revenue / Employee
2.19M
Employees
3,471
Market Cap
23.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 7.17B | 975.27M | 15.74% |
| Mar 31, 2024 | 6.20B | 1.33B | 27.20% |
| Mar 31, 2023 | 4.87B | 316.73M | 6.95% |
| Mar 31, 2022 | 4.55B | 589.94M | 14.88% |
| Mar 31, 2021 | 3.96B | 1.38B | 53.41% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |
Krsnaa Diagnostics News
- 17 days ago - Krsnaa Diagnostics approves Rs 430 crore fundraise via NCDs - Business Upturn
- 7 weeks ago - Krsnaa Diagnostics shares jump over 3% as Q2 revenue rises 10.5% YoY to Rs 206 crore, net profit rose 21.9% - Business Upturn
- 4 months ago - Krsnaa Diagnostics shares fall over 3% following Q1 results - Business Upturn
- 6 months ago - Krsnaa Diagnostics gets Rajasthan High Court nod, to proceed with NHM lab services contract - Business Upturn
- 8 months ago - Top stocks to buy today: Stock recommendations for April 23, 2025 - The Times of India
- 1 year ago - Lab stops blood collection at 400 BMC hosps over pending dues - The Times of India
- 1 year ago - Krsnaa Diagnostics shares surge nearly 6% as Q2 net sales reach ₹186.34 crore - Business Upturn
- 1 year ago - Stock in Focus: Krsnaa Diagnostics secures two major agreements in Ranchi - Business Upturn